A phosphorylation-wide sncRNA screen reveals Protein Functional Effector sncRNAs (pfeRNAs) in human lung somatic cells.

作者: Tyler Gable , Yuyan Wang , David Clark , Priti Kumari , Amol Carl Shetty

DOI: 10.1016/J.CANLET.2017.03.017

关键词:

摘要: We recently reported that PIWI-interacting RNAs likes (piR-Ls) could regulate functions of the interacting phosphorylated proteins (p-Proteins). In addition, except for writers and erasers, functional efficacy p-Proteins on their readers still remains unknown. We, therefore, reasoned there was a type sncRNAs which p-Proteins. Here, we profiled with -Ser, -Thr -Tyr residues in 3 HBE 4 lung SCC cell lines, investigated effects mechanisms phosphorylated-residue-interacting sncRNAs. Our results demonstrated regulating thus referred them as Protein Functional Effector (pfeRNAs). pfeRNAs were distributed among 26 to 50 nucleotides, shared some core sequences showed distinctive expression patterns between cells. Core 417 (CS417), showing consistent upregulation all cells, bound directly p-Nucleolin (NCL), dependent key elements CGCG CS417 p-Ser619 NCL. The CS417/p-NCL interaction critical p-NCL basic activities normal cancer Thus, revealed novel controlling somatic

参考文章(53)
Tetsuya Mitsudomi, Yasushi Yatabe, Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer FEBS Journal. ,vol. 277, pp. 301- 308 ,(2010) , 10.1111/J.1742-4658.2009.07448.X
Meera Srivastava, Harvey B. Pollard, Molecular dissection of nucleolin’s role in growth and cell proliferation: new insights The FASEB Journal. ,vol. 13, pp. 1911- 1922 ,(1999) , 10.1096/FASEBJ.13.14.1911
Andrew Fire, SiQun Xu, Mary K. Montgomery, Steven A. Kostas, Samuel E. Driver, Craig C. Mello, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature. ,vol. 391, pp. 806- 811 ,(1998) , 10.1038/35888
Stephen M. Vogel, Asrar B. Malik, Cytoskeletal dynamics and lung fluid balance Comprehensive Physiology. ,vol. 2, pp. 449- 478 ,(2012) , 10.1002/CPHY.C100006
Masatoshi Takagi, Michael J. Absalon, Kevin G. McLure, Michael B. Kastan, Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin Cell. ,vol. 123, pp. 49- 63 ,(2005) , 10.1016/J.CELL.2005.07.034
Luis Paz-Ares, Denis Soulières, Ivan Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell, Barbara Klughammer, Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis Journal of Cellular and Molecular Medicine. ,vol. 14, pp. 51- 69 ,(2010) , 10.1111/J.1582-4934.2009.00991.X
Carlos Salazar, Thomas Höfer, Multisite protein phosphorylation – from molecular mechanisms to kinetic models FEBS Journal. ,vol. 276, pp. 3177- 3198 ,(2009) , 10.1111/J.1742-4658.2009.07027.X
Rafael Rosell, Teresa Morán, Enric Carcereny, Vanessa Quiroga, Miguel Ángel Molina, Carlota Costa, Susana Benlloch, Miquel Tarón, Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain Clinical & Translational Oncology. ,vol. 12, pp. 75- 80 ,(2010) , 10.1007/S12094-010-0473-0
James E. Ferrell, Jr, Sang Hoon Ha, Ultrasensitivity part II: multisite phosphorylation, stoichiometric inhibitors, and positive feedback Trends in Biochemical Sciences. ,vol. 39, pp. 556- 569 ,(2014) , 10.1016/J.TIBS.2014.09.003
June Koo Lee, Tae Min Kim, Youngil Koh, Se-Hoon Lee, Dong-Wan Kim, Yoon-Kyung Jeon, Doo Hyun Chung, Seok-Chul Yang, Young Tae Kim, Young-Whan Kim, Dae Seog Heo, Yung-Jue Bang, None, Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation. Lung Cancer. ,vol. 77, pp. 460- 463 ,(2012) , 10.1016/J.LUNGCAN.2012.04.012